<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BOKU-Vienna_Notebook skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BOKU-Vienna/Notebook</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-main-collapse">
                Menu </BUTTON><A class="navbar-brand page-scroll" href="https://2017.igem.org/Team:BOKU-Vienna">
                D.I.V.E.R.T.
            </A></DIV><DIV class="collapse navbar-collapse navbar-right navbar-main-collapse"><UL class="nav navbar-nav"><LI class="dropdown-li"><DIV class="dropdown"><A class="dropdown-toggle" type="button" id="dropdown2" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Team
                      </A></DIV></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Team" class="dropdown-a">Team</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" class="dropdown-a">Collaborations</A></LI></UL></DIV><LI class="dropdown-li"><DIV class="dropdown"><A class="dropdown-toggle" type="button" id="dropdown3" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Project
                      </A></DIV></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Description" class="dropdown-a">Theory</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Experiments" class="dropdown-a">Experiments</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Discussion" class="dropdown-a">Discussion</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Notebook" class="dropdown-a">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Protocol" class="dropdown-a">Protocol</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Model" class="dropdown-a">Modeling</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Demonstrate" class="dropdown-a">Demonstrate</A></LI></DIV><LI class="dropdown-li"><DIV class="dropdown"><A class="dropdown-toggle" type="button" id="dropdown4" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Parts
                      </A></DIV></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Parts" class="dropdown-a">Overview</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Basic_Part" class="dropdown-a">Basic Part</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Part_Collection" class="dropdown-a">Part Collection</A></LI></DIV><LI class="dropdown-li"><DIV class="dropdown"><A class="dropdown-toggle" type="button" id="dropdown1" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Human Practices
                      </A></DIV></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/HP/Silver" class="dropdown-a">Silver HP</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/HP/Gold_Integrated" class="dropdown-a">Integrated and Gold</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Engagement" class="dropdown-a">Public Engagement</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/HP/Newsletters" class="dropdown-a">Newsletters</A></LI></DIV><LI class="dropdown-li"><DIV class="dropdown"><A onclick="window.location.href='https://2017.igem.org/Team:BOKU-Vienna/Safety'" class="dropdown-toggle" type="button" id="dropdown1" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Safety
                      </A></DIV></LI><LI class="dropdown-li"><DIV class="dropdown"><A class="dropdown-toggle" type="button" id="dropdown6" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Medal Criteria
                      </A></DIV></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/MedalCriteria" class="dropdown-a">Overview</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Attributions" class="dropdown-a">Attributions</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" class="dropdown-a">Interlab</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Improve" class="dropdown-a">Improve</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Model" class="dropdown-a">Modeling</A></LI><LI><A href="https://2017.igem.org/Team:BOKU-Vienna/Contribution" class="dropdown-a">Contribution</A></LI></DIV><LI class="dropdown-li"><DIV class="dropdown"><A onclick="window.location.href='https://2017.igem.org/Team:BOKU-Vienna/Sponsors'" class="dropdown-toggle" type="button" id="dropdown7" data-toggle="dropdown" aria-haspopup="true" aria-expanded="true">
                        Sponsors
                      </A></DIV></LI></DIV></DIV><DIV id="page-top" data-spy="scroll" data-target=".navbar-fixed-top"><NAV class="navbar scrollnav-custom navbar-fixed-bottom" role="navigation" id="scrollnav"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-main-collapse">
                    Menu </BUTTON></DIV><DIV class="collapse navbar-collapse navbar-right navbar-main-collapse"><UL class="nav navbar-nav"><LI><A class="page-scroll" href="#">Top</A></LI><LI><A class="page-scroll" href="#Notebook">Notebook</A></LI></UL></DIV></DIV></NAV><HEADER class="myintro"><DIV class="myintro-body"><DIV class="container"><DIV class="row"><DIV class="col-md-8 col-md-offset-2"><H1 class="brand-heading">Notebook</H1></DIV></DIV></DIV></DIV></HEADER><SECTION id="Notebook" class="container content-section text-center"><DIV class="row"><DIV class="col-lg-8 col-lg-offset-2"><H2>Notebook.</H2><P>All protocols we used for the methods can be found here: 
<A href="https://2017.igem.org/Team:BOKU-Vienna/Protocol" target="_blank">Protocol</A>For further information regarding our Golden Gate Assembly products, we refer to our <A href="https://2017.igem.org/Team:BOKU-Vienna/Part_Collection" target="_blank">part collection</A> site. The list of our primers can be found <A href="https://static.igem.org/mediawiki/2017/e/ea/T--BOKU-Vienna--Primerliste.pdf" target="_blank">here</A>.
</P></DIV></DIV><PRE><A href="#week1" id="scrollnav" class="arrows" onclick="expand_collapse('1');"><FONT size="+2"><B>Week 1</B></FONT> (03/07-07/07)</A></PRE><DIV id="1" class="yolo" style="display:none;"><P>   • Preparation of growth media    • Interlab Challenge 2017: Transformations of the plasmids into <I>E. coli</I> DH5α. For more information, please visit our <A href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</A> site.    • <I>E. Coli</I> DH10B cells were made chemically competent.   • Miniprep of GG plasmids:
<A href="#BB1_01" class="bgscroll"> BB1_01</A>, <A href="#BB1_02" class="bgscroll"> BB1_02</A>, <A href="#BB1_03" class="bgscroll"> BB1_03</A>, <A href="#BB1_04" class="bgscroll"> BB1_04</A>, <A href="#BB1_05" class="bgscroll"> BB1_05</A>, <A href="#BB1_06" class="bgscroll"> BB1_06</A>, <A href="#BB1_07" class="bgscroll"> BB1_07</A>, <A href="#BB1_08" class="bgscroll"> BB1_08</A></P><DIV id="BB1_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_02" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_03" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_04" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_05" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_06" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_07" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_08" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week2" id="Week 2" class="arrows" onclick="expand_collapse('2');"><FONT size="+2"><B>Week 2</B></FONT> (10/07-14/07)</A></PRE><DIV id="2" class="yolo" style="display:none;"><P>• PCR: #1, #2, #3, #4, #6, #15, #18, #20, #23, #24, #25, #26
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB1_09" class="bgscroll"> BB1_09</A>, <A href="#BB1_10" class="bgscroll"> BB1_10</A>, <A href="#BB1_11" class="bgscroll"> BB1_11</A>, <A href="#BB1_12" class="bgscroll"> BB1_12</A>, <A href="#BB1_13" class="bgscroll"> BB1_13</A>, BB2_01 (unsuccessful), <A href="#BB2_02" class="bgscroll"> BB2_02</A>, <A href="#BB2_03" class="bgscroll"> BB2_03</A>, <A href="#BB2_04" class="bgscroll"> BB2_04</A>, BB2_05 (unsuccessful)
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• pSIM5 pre-cultures (DH5alpha + BL21(DE3))• Transformation of HSM174 + pSIM5 (unsuccessful)• Yeast S288C gDNA extraction • Interlab Challenge 2017: Performance of the measurements. For more information, please visit our <A href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</A> site.</P><DIV id="BB1_09" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_11" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_12" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_13" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_02" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_03" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_04" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week3" id="Week 3" class="arrows" onclick="expand_collapse('3');"><FONT size="+2"><B>Week 3</B></FONT> (17/07-21/07)</A></PRE><DIV id="3" class="yolo" style="display:none;"><P>• PCR: #27, #28
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB1_14" class="bgscroll"> BB1_14</A>, <A href="#BB1_15" class="bgscroll"> BB1_15</A>, BB2_01 (unsuccessful, even with new BBa_23101 promoter), BB2_05 (unsuccessful), <A href="#BB2_06" class="bgscroll"> BB2_06</A>, <A href="#BB2_07" class="bgscroll"> BB2_07</A>, <A href="#BB2_08" class="bgscroll"> BB2_08</A>, <A href="#BB2_09" class="bgscroll"> BB2_09</A>, <A href="#BB2_10" class="bgscroll"> BB2_10</A>, <A href="#BB2_12" class="bgscroll"> BB2_12</A>, <A href="#BB2_14" class="bgscroll"> BB2_14</A>, <A href="#BB2_15" class="bgscroll"> BB2_15</A>, <A href="#BB2_16" class="bgscroll"> BB2_16</A>, C-PPP_01 (unsuccessful)
GG-products were transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Sent for Sequencing: <A href="#BB1_14" class="bgscroll"> BB1_14</A>, <A href="#BB1_15" class="bgscroll"> BB1_15</A>,  <A href="#BB2_01" class="bgscroll"> BB2_01</A>, <A href="#BB2_05" class="bgscroll"> BB2_05</A>, <A href="#BB2_06" class="bgscroll"> BB2_06</A>, <A href="#BB2_07" class="bgscroll"> BB2_07</A>, <A href="#BB2_08" class="bgscroll"> BB2_08</A>, <A href="#BB2_09" class="bgscroll"> BB2_09</A>, <A href="#BB2_10" class="bgscroll"> BB2_10</A>, <A href="#BB2_12" class="bgscroll"> BB2_12</A></P><DIV id="BB1_14" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_15" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_05" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_06" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_07" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_08" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_09" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_12" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_14" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_15" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_16" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week4" id="Week 4" class="arrows" onclick="expand_collapse('4');"><FONT size="+2"><B>Week 4</B></FONT> (24/07-28/07)</A></PRE><DIV id="4" class="yolo" style="display:none;"><P>• PCR: #9, #10, #16, #29, #30, #31, #32, #33, #34, #35, #36, #41, #42, #43
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB1_16" class="bgscroll"> BB1_16</A>, <A href="#BB1_17" class="bgscroll"> BB1_17</A>, <A href="#BB1_18" class="bgscroll"> BB1_18</A>, <A href="#BB1_20" class="bgscroll"> BB1_20</A>, <A href="#BB1_21" class="bgscroll"> BB1_21</A>,  <A href="#BB1_22" class="bgscroll"> BB1_22</A>, <A href="#BB1_23" class="bgscroll"> BB1_23</A>, <A href="#BB1_24" class="bgscroll"> BB1_24</A>, <A href="#BB1_25" class="bgscroll"> BB1_25</A>, <A href="#BB2_17" class="bgscroll"> BB2_17</A>, <A href="#BB2_23" class="bgscroll"> BB2_23</A>, <A href="#BB2_24" class="bgscroll"> BB2_24</A>, BB3_01 (unsuccessful), <A href="#BB3_02" class="bgscroll"> BB3_02</A>, <A href="#BB3_04" class="bgscroll"> BB3_04</A>, <A href="#BB3_05" class="bgscroll"> BB3_05</A>, <A href="#BB3_06" class="bgscroll"> BB3_06</A> (doubtful), <A href="#BB3_08" class="bgscroll"> BB3_08</A>


GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Yeast S266C were made electro-competent.• Sent for Sequencing: <A href="#BB1_16" class="bgscroll"> BB1_16</A>, <A href="#BB1_17" class="bgscroll"> BB1_17</A>, <A href="#BB1_18" class="bgscroll"> BB1_18</A>, <A href="#BB3_02" class="bgscroll"> BB3_02</A>, <A href="#BB3_05" class="bgscroll"> BB3_05</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_01</A></P><DIV id="BB1_16" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_17" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_18" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_20" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_21" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_22" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_23" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_24" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB1_25" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_17" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_23" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_24" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_02" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_04" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_05" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_06" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_08" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week5" id="Week 5" class="arrows" onclick="expand_collapse('5');"><FONT size="+2"><B>Week 5</B></FONT> (31/07-04/08)</A></PRE><DIV id="5" class="yolo" style="display:none;"><P>• PCR: #41, #42, #45, #52, #53, #56, #57
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB1_19" class="bgscroll"> BB1_19</A>, <A href="#BB2_19" class="bgscroll"> BB2_19</A>, <A href="#BB2_25" class="bgscroll"> BB2_25</A>, <A href="#BB2_26" class="bgscroll"> BB2_26</A>,<A href="#BB2_27" class="bgscroll"> BB2_27</A>, <A href="#BB2_28" class="bgscroll"> BB2_28</A>, <A href="#BB2_29" class="bgscroll"> BB2_29</A>, <A href="#BB2_30" class="bgscroll"> BB2_30</A>, <A href="#BB2_31" class="bgscroll"> BB2_31</A>, <A href="#BB2_32" class="bgscroll"> BB2_32</A>, <A href="#BB2_33" class="bgscroll"> BB2_33</A>, <A href="#BB2_34" class="bgscroll"> BB2_34</A>, BB3_01 (unsuccessful), <A href="#BB3_02" class="bgscroll"> BB3_02</A>, BB3_03 (unsuccessful), <A href="#BB3_06" class="bgscroll"> BB3_06</A>, <A href="#BB3_10" class="bgscroll"> BB3_10</A>, <A href="#BB3_13" class="bgscroll"> BB3_13</A>, <A href="#BB3_14" class="bgscroll"> BB3_14</A>, <A href="#BB3_15" class="bgscroll"> BB3_15</A>, <A href="#BB3_24" class="bgscroll"> BB3_24</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• DH10B <I>E. coli</I> strain was made chemically competent.• Yeast cells were transformed with the Cas9 plasmid.• Sent for Sequencing: <A href="#BB1_19" class="bgscroll"> BB1_19</A>, <A href="#BB2_34" class="bgscroll"> BB2_34</A>, <A href="#BB3_12" class="bgscroll"> BB3_12</A>, <A href="#BB3_13" class="bgscroll"> BB3_13</A>, <A href="#BB3_14" class="bgscroll"> BB3_14</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_02</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_03</A></P><DIV id="BB1_19" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_19" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_25" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_26" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_27" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_28" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_29" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_30" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_31" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_32" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_33" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_34" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_02" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_06" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_12" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_13" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_14" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_15" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_24" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week6" id="Week 6" class="arrows" onclick="expand_collapse('6');"><FONT size="+2"><B>Week 6</B></FONT> (07/08-11/08)</A></PRE><DIV id="6" class="yolo" style="display:none;"><P>• Golden Gate Assembly of <A href="#BB2_36" class="bgscroll"> BB2_36</A>, <A href="#BB3_07" class="bgscroll"> BB3_07</A>, <A href="#BB3_10" class="bgscroll"> BB3_10</A>, <A href="#BB3_11" class="bgscroll"> BB3_11</A>, <A href="#BB3_13" class="bgscroll"> BB3_13</A>, <A href="#BB3_14" class="bgscroll"> BB3_14</A>, <A href="#BB3_17" class="bgscroll"> BB3_17</A>, <A href="#BB3_18" class="bgscroll"> BB3_18</A>, <A href="#BB3_19" class="bgscroll"> BB3_19</A>, <A href="#BB3_20" class="bgscroll"> BB3_20</A>, <A href="#BB3_21" class="bgscroll"> BB3_21</A>, <A href="#BB3_22" class="bgscroll"> BB3_22</A>, <A href="#BB3_23" class="bgscroll"> BB3_23</A>, <A href="#BB3_24" class="bgscroll"> BB3_24</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_03</A>, <A href="#C-PPP_04" class="bgscroll"> C-PPP_04</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected  by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• A temperature-sensitivity test was performed for cells with pSIM5, a temperature sensitive plasmid. An overnight culture was incubated at 37°C and a control was incubated at 28°C. The overnight culture at 37°C was tested as positive and lost the plasmid, while the control maintained its plasmid.• Two clones of yeast cells carrying the Cas9 plasmid were made competent for the next transformation.• Sent for Sequencing: <A href="#BB2_19" class="bgscroll"> BB2_19</A>, <A href="#BB2_21" class="bgscroll"> BB2_21</A>, <A href="#BB2_31" class="bgscroll"> BB2_31</A>, <A href="#BB2_32" class="bgscroll"> BB2_32</A>, <A href="#BB2_33" class="bgscroll"> BB2_33</A>, <A href="#BB2_34" class="bgscroll"> BB2_34</A>, <A href="#BB3_01" class="bgscroll"> BB3_01</A>, <A href="#BB3_13" class="bgscroll"> BB3_13</A>, <A href="#BB3_14" class="bgscroll"> BB3_14</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_02</A>, <A href="#C-PPP_01" class="bgscroll"> C-PPP_03</A></P><DIV id="BB2_19" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_21" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_31" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_32" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_33" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_34" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_36" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_07" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_11" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_13" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_14" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_17" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_18" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_19" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_21" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_23" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_24" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_04" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_20" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_22" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week7" id="Week 7" class="arrows" onclick="expand_collapse('7');"><FONT size="+2"><B>Week 7</B></FONT> (14/08-18/08)</A></PRE><DIV id="7" class="yolo" style="display:none;"><P>• Golden Gate Assembly of <A href="#BB1_26" class="bgscroll"> BB1_26</A>, <A href="#BB2_23" class="bgscroll"> BB2_23</A>, BB3_02 (unsuccessful), <A href="#BB3_12" class="bgscroll"> BB3_12</A>, <A href="#BB3_16" class="bgscroll"> BB3_16</A>, <A href="#BB3_17" class="bgscroll"> BB3_17</A>, <A href="#BB3_20" class="bgscroll"> BB3_20</A>, <A href="#BB3_22" class="bgscroll"> BB3_22</A>, BB3_28 (unsuccessful), <A href="#C-PPP_04" class="bgscroll"> C-PPP_05</A>, <A href="#C-PPP_04" class="bgscroll"> C-PPP_06</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Overnight cultures of <A href="#C-PPP_04" class="bgscroll"> C-PPP_04</A> were tested for temperature sensitivity.• Sent for Sequencing: <A href="#C-PPP_04" class="bgscroll"> C-PPP_05</A>, <A href="#C-PPP_04" class="bgscroll"> C-PPP_06</A>, <A href="#BB3_20" class="bgscroll"> BB3_20</A>, <A href="#BB3_22" class="bgscroll"> BB3_22</A></P><DIV id="BB1_26" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_23" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_12" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_16" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_17" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_20" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_22" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_28" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_04" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week8" id="Week 8" class="arrows" onclick="expand_collapse('8');"><FONT size="+2"><B>Week 8</B></FONT> (21/08-25/08)</A></PRE><DIV id="8" class="yolo" style="display:none;"><P>• PCR: #71, #72
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol.
• Golden Gate Assembly of <A href="#BB1_27" class="bgscroll"> BB1_27</A>, BB3_01 (unsuccessful), <A href="#BB3_03" class="bgscroll"> BB3_03</A>, <A href="#BB3_30" class="bgscroll"> BB3_30</A>, <A href="#BB3_31" class="bgscroll"> BB3_31</A>, <A href="#BB3_32" class="bgscroll"> BB3_32</A>, <A href="#BB3_33" class="bgscroll"> BB3_33</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Transformation of <A href="#BB3_32" class="bgscroll"> BB3_32</A> and <A href="#BB3_31" class="bgscroll"> BB3_31</A> into yeast cells• <A href="#BB3_31" class="bgscroll"> BB3_31</A> and <A href="#BB3_32" class="bgscroll"> BB3_32</A> cultivated in YP+G418: for testing the GFP expression, measurement in a plate reader. 


</P><DIV id="BB1_27" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_03" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_30" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_31" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_32" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_33" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week9" id="Week 9" class="arrows" onclick="expand_collapse('9');"><FONT size="+2"><B>Week 9</B></FONT> (28/08-01/09)</A></PRE><DIV id="9" class="yolo" style="display:none;"><P>Improving BBa_E0040: PCRs for removing the illegal BsaI restricion site. Golden Gate Assembly of the PCRs and cloning into the pSB1C3. For more information please visit: 
<A href="https://2017.igem.org/Team:BOKU-Vienna/Improve" target="_blank">Improve</A>• Golden Gate Assembly of BB3_01 (unsuccessful), <A href="#C-PPP_07" class="bgscroll">C-PPP_07</A>, <A href="#C-PPP_07" class="bgscroll"> C-PPP_08</A>,  <A href="#C-PPP_07" class="bgscroll"> C-PPP_09</A>, <A href="#C-PPP_10" class="bgscroll">C-PPP_10</A>, <A href="#BB3_33" class="bgscroll">BB3_33</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Minipreparation for plasmid DNA extraction: <A href="#BB3_12" class="bgscroll">BB3_12</A>, <A href="#BB3_30" class="bgscroll">BB3_30</A>, <A href="#BB3_15" class="bgscroll">BB3_15</A>• Transformation of pSIM9</P><DIV id="BB3_35" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_01" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_33" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_12" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_30" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_15" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_07" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week10" id="Week 10" class="arrows" onclick="expand_collapse('10');"><FONT size="+2"><B>Week 10</B></FONT> (04/09-08/09)</A></PRE><DIV id="10" class="yolo" style="display:none;"><P>• PCR: #88, #89, #90

Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of  <A href="#BB3_12" class="bgscroll"> BB3_12</A>, <A href="#BB3_34" class="bgscroll"> BB3_34</A>, <A href="#BB3_35 Speziale" class="bgscroll"> BB3_35 Speziale</A>, <A href="#BB3_35" class="bgscroll"> BB3_35</A>, <A href="#BB3_36" class="bgscroll"> BB3_36</A>, <A href="#BB3_37" class="bgscroll"> BB3_37</A>, <A href="#BB3_38" class="bgscroll"> BB3_38</A>, <A href="#C-PPP_10" class="bgscroll"> C-PPP_12</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Lethality-Test of <A href="#C-PPP_10" class="bgscroll"> C-PPP_11</A> and <A href="#C-PPP_10" class="bgscroll"> C-PPP_12</A></P><DIV id="BB3_34" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_35 Speziale" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_35" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_36" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_37" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_38" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week11" id="Week 11" class="arrows" onclick="expand_collapse('11');"><FONT size="+2"><B>Week 11</B></FONT> (11/09-15/09)</A></PRE><DIV id="11" class="yolo" style="display:none;"><P>• Golden Gate Assembly of <A href="#BB3_27" class="bgscroll"> BB3_27</A>, <A href="#BB3_36" class="bgscroll"> BB3_36</A>, <A href="#BB3_37" class="bgscroll"> BB3_37</A>, <A href="#BB3_38" class="bgscroll"> BB3_38</A>, <A href="#BB3_39" class="bgscroll"> BB3_39</A>, <A href="#BB3_40" class="bgscroll"> BB3_40</A>, <A href="#BB3_43" class="bgscroll"> BB3_43</A>, <A href="#C-PPP_10" class="bgscroll"> C-PPP_10</A>, <A href="#C-PPP_10" class="bgscroll"> C-PPP_11</A>, <A href="#C-PPP_10" class="bgscroll"> C-PPP_12</A>, C-PPP_12 (+ #97)
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Transformation and OneTaq colony PCR of yeast</P><DIV id="BB3_27" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_36" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_37" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_38" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_39" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_40" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_43" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_10" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week12" id="Week 12" class="arrows" onclick="expand_collapse('12');"><FONT size="+2"><B>Week 12</B></FONT> (18/09-22/09)</A></PRE><DIV id="12" class="yolo" style="display:none;"><P>• PCR: #102, #103, #105, #106
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB2_56" class="bgscroll">BB2_56</A>, <A href="#BB3_09" class="bgscroll"> BB3_09</A>, <A href="#BB3_42" class="bgscroll"> BB3_42</A>, C-PPP_15 (unsuccessful), <A href="#C-PPP_25" class="bgscroll"> C-PPP_26</A>, C-PPP_27 (unsuccessful), <A href="#C-PPP_28" class="bgscroll"> C-PPP_28</A>, <A href="#C-PPP_31" class="bgscroll"> C-PPP_31</A>, <A href="#C-PPP_34" class="bgscroll"> C-PPP_34</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Yeast S288C were made electro-competent.• Toulouse Collaboration: For further information, please visit our <A href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target="_&quot;blank&quot;">Collaboration</A> site.</P><DIV id="BB2_56" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_09" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_42" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_25" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_28" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_31" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_34" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week13" id="Week 13" class="arrows" onclick="expand_collapse('13');"><FONT size="+2"><B>Week 13</B></FONT> (25/09-29/09)</A></PRE><DIV id="13" class="yolo" style="display:none;"><P>• PCR: #5, #110, #126, #127, #131
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification.
• Golden Gate Assembly of <A href="#BB1_32" class="bgscroll"> BB1_32</A>, <A href="#BB2_51" class="bgscroll"> BB2_51</A>, <A href="#BB2_52" class="bgscroll"> BB2_52</A>, <A href="#BB2_53" class="bgscroll"> BB2_53</A>, <A href="#BB2_54" class="bgscroll"> BB2_54</A>, <A href="#BB2_55" class="bgscroll"> BB2_55</A>, <A href="#BB2_57" class="bgscroll"> BB2_57</A>, BB3_41 (unsuccessful), <A href="#BB3_43" class="bgscroll"> BB3_43</A>, <A href="#BB3_45" class="bgscroll"> BB3_45</A>, <A href="#BB3_46" class="bgscroll"> BB3_46</A>, <A href="#BB3_47" class="bgscroll"> BB3_47</A>, <A href="#BB3_48" class="bgscroll"> BB3_48</A>, <A href="#BB3_49" class="bgscroll"> BB3_49</A>, <A href="#C-PPP_13" class="bgscroll"> C-PPP_14</A>, <A href="#C-PPP_13" class="bgscroll"> C-PPP_15</A>, <A href="#C-PPP_16" class="bgscroll"> C-PPP_16</A>, <A href="#C-PPP_19" class="bgscroll"> C-PPP_19</A>, <A href="#C-PPP_19" class="bgscroll"> C-PPP_20</A>, <A href="#C-PPP_19" class="bgscroll"> C-PPP_21</A>, <A href="#C-PPP_22" class="bgscroll"> C-PPP_22</A>, <A href="#C-PPP_28" class="bgscroll"> C-PPP_28</A>, <A href="#C-PPP_31" class="bgscroll"> C-PPP_31</A>, <A href="#C-PPP_31" class="bgscroll"> C-PPP_33</A>, <A href="#C-PPP_31" class="bgscroll"> C-PPP_33</A>, <A href="#C-PPP_34" class="bgscroll"> C-PPP_34</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.• Heidelberg Collaboration: For further information, please visit our <A href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target="_&quot;blank&quot;">Collaboration</A> site.</P><DIV id="BB1_32" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_51" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_52" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_53" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_54" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_55" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB2_57" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_43" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_45" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_46" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_47" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_48" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="BB3_49" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_13" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_19" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_22" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_28" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_31" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV><DIV id="C-PPP_34" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week14" id="Week 14" class="arrows" onclick="expand_collapse('14');"><FONT size="+2"><B>Week 14</B></FONT> (02/10-06/10)</A></PRE><DIV id="14" class="yolo" style="display:none;"><P>• Golden Gate Assembly of <A href="#C-PPP_37" class="bgscroll"> C-PPP_37</A>, <A href="#C-PPP_37" class="bgscroll"> C-PPP_38</A>, <A href="#C-PPP_37" class="bgscroll"> C-PPP_39</A>
GG-products were then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.
</P><DIV id="C-PPP_37" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV><PRE><A href="#week15" id="Week 15" class="arrows" onclick="expand_collapse('15');"><FONT size="+2"><B>Week 15</B></FONT> (09/10-13/10)</A></PRE><DIV id="15" class="yolo" style="display:none;"><P>• Lethality Test of <A href="#C-PPP_37" class="bgscroll"> C-PPP_38</A>, <A href="#C-PPP_37" class="bgscroll"> C-PPP_39</A>• RT activity assay • Lethality Test of C-PPP 24 and 30 • Transformation of <A href="#C-PPP_37" class="bgscroll"> C-PPP_38</A>, <A href="#C-PPP_37" class="bgscroll"> C-PPP_39</A> into <I>E.coli</I> with pSIM9.
Positive clones were made electro-competent and the lambda-red system was induced. • Integration: GFPuv into <I>E. coli</I> DH10B using <A href="#C-PPP_37" class="bgscroll"> C-PPP_39</A> and pSIM9</P><DIV id="C-PPP_37" class="modalDialog "><DIV><A href="#close" title="Close" class="close">X</A></DIV></DIV></DIV></SECTION></DIV></BODY></HTML>